ALDR
Point72 Asset Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-18,200
| Closed | -$214K | – | 1517 |
|
|
2019
Q2 | $214K | Buy |
+18,200
| New | +$214K | ﹤0.01% | 870 |
|
|
2019
Q1 | – | Sell |
-450,500
| Closed | -$4.62M | – | 1208 |
|
|
2018
Q4 | $4.62M | Buy |
+450,500
| New | +$4.62M | 0.02% | 498 |
|
|
2018
Q3 | – | Sell |
-123,800
| Closed | -$1.96M | – | 1148 |
|
|
2018
Q2 | $1.96M | Buy |
+123,800
| New | +$1.96M | 0.01% | 603 |
|
|
2017
Q4 | – | Sell |
-111,146
| Closed | -$1.36M | – | 1010 |
|
|
2017
Q3 | $1.36M | Sell |
111,146
-158,654
| -59% | -$1.94M | 0.01% | 593 |
|
|
2017
Q2 | $3.09M | Buy |
+269,800
| New | +$3.09M | 0.02% | 489 |
|
|
2016
Q3 | – | Sell |
-47,100
| Closed | -$1.18M | – | 846 |
|
|
2016
Q2 | $1.18M | Sell |
47,100
-1,106,700
| -96% | -$27.6M | 0.01% | 550 |
|
|
2016
Q1 | $28.3M | Sell |
1,153,800
-130,000
| -10% | -$3.18M | 0.22% | 117 |
|
|
2015
Q4 | $42.4M | Buy |
1,283,800
+94,100
| +8% | +$3.11M | 0.35% | 71 |
|
|
2015
Q3 | $39M | Buy |
1,189,700
+370,300
| +45% | +$12.1M | 0.31% | 85 |
|
|
2015
Q2 | $43.4M | Buy |
819,400
+400,167
| +95% | +$21.2M | 0.3% | 82 |
|
|
2015
Q1 | $12.1M | Buy |
419,233
+409,933
| +4,408% | +$11.8M | 0.08% | 266 |
|
|
2014
Q4 | $271K | Buy |
+9,300
| New | +$271K | ﹤0.01% | 589 |
|